Literature DB >> 19116643

Improving clinical trial design for inquiries into the mechanisms of cyst growth in ADPKD.

Arlene B Chapman1.   

Abstract

Accurate and reliable estimates of kidney and cyst volume, the hallmark of disease progression in ADPKD are now available. These powerful and exciting tools make it possible to consider both short and long term randomized clinical trials in ADPKD at various stages of disease. Highlights of the work by Kistler and colleagues are now provided.

Entities:  

Mesh：

Year:  2009        PMID： 19116643      PMCID： PMC2693222          DOI： 10.1038/ki.2008.596

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  5 in total

Review 1.  Magnetic resonance nephrourography: current and developing techniques.

Authors:  Bobby Kalb; John R Votaw; Khalil Salman; Puneet Sharma; Diego R Martin
Journal:  Radiol Clin North Am       Date:  2008-01       Impact factor: 2.303

2.  Volume progression in polycystic kidney disease.

Authors:  Jared J Grantham; Vicente E Torres; Arlene B Chapman; Lisa M Guay-Woodford; Kyongtae T Bae; Bernard F King; Louis H Wetzel; Deborah A Baumgarten; Phillip J Kenney; Peter C Harris; Saulo Klahr; William M Bennett; Gladys N Hirschman; Catherine M Meyers; Xiaoling Zhang; Fang Zhu; John P Miller
Journal:  N Engl J Med       Date:  2006-05-18       Impact factor: 91.245

3.  Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.

Authors:  Bernard F King; Vicente E Torres; Marijn E Brummer; Arlene B Chapman; Kyongtae T Bae; James F Glockner; Kraisthith Arya; Joel P Felmlee; Jared J Grantham; Lisa M Guay-Woodford; William M Bennett; Saulo Klahr; Gladys H Hirschman; Paul L Kimmel; Paul A Thompson; J Phillip Miller
Journal:  Kidney Int       Date:  2003-12       Impact factor: 10.612

4.  Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months.

Authors:  Andreas D Kistler; Diane Poster; Fabienne Krauer; Dominik Weishaupt; Shagun Raina; Oliver Senn; Isabelle Binet; Katharina Spanaus; Rudolf P Wüthrich; Andreas L Serra
Journal:  Kidney Int       Date:  2008-10-29       Impact factor: 10.612

5.  Computed tomography evaluation of autosomal dominant polycystic kidney disease progression: a progress report.

Authors:  Luca Antiga; Marina Piccinelli; Giorgio Fasolini; Bogdan Ene-Iordache; Patrizia Ondei; Simona Bruno; Giuseppe Remuzzi; Andrea Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2006-06-14       Impact factor: 8.237
  5 in total
  3 in total

1.  Intermediate volume on computed tomography imaging defines a fibrotic compartment that predicts glomerular filtration rate decline in autosomal dominant polycystic kidney disease patients.

Authors:  Anna Caroli; Luca Antiga; Sara Conti; Aurelio Sonzogni; Giorgio Fasolini; Patrizia Ondei; Norberto Perico; Giuseppe Remuzzi; Andrea Remuzzi
Journal:  Am J Pathol       Date:  2011-06-17       Impact factor: 4.307

2.  Sirolimus therapy to halt the progression of ADPKD.

Authors:  Norberto Perico; Luca Antiga; Anna Caroli; Piero Ruggenenti; Giorgio Fasolini; Mariateresa Cafaro; Patrizia Ondei; Nadia Rubis; Olimpia Diadei; Giulia Gherardi; Silvia Prandini; Andrea Panozo; Rodolfo Flores Bravo; Sergio Carminati; Felipe Rodriguez De Leon; Flavio Gaspari; Monica Cortinovis; Nicola Motterlini; Bogdan Ene-Iordache; Andrea Remuzzi; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2010-05-13       Impact factor: 10.121

3.  Standardizing total kidney volume measurements for clinical trials of autosomal dominant polycystic kidney disease.

Authors:  Marie E Edwards; Jaime D Blais; Frank S Czerwiec; Bradley J Erickson; Vicente E Torres; Timothy L Kline
Journal:  Clin Kidney J       Date:  2018-08-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.